TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biotage AB
Closing information (x1000 EUR)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
167,808
|
140,722
|
120,467 |
Financial expenses |
3,695
|
1,258
|
1,173 |
Earnings before taxes |
27,307
|
31,272
|
26,303 |
EBITDA |
41,727
|
38,550
|
33,930 |
Total assets |
444,394
|
210,185
|
194,780 |
Current assets |
130,407
|
92,647
|
75,683 |
Current liabilities |
63,176
|
37,202
|
30,312 |
Equity capital |
329,578
|
147,102
|
134,058 |
- share capital |
10,094
|
8,357
|
8,996 |
Employees (average) |
674
|
517
|
497 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
74.2%
|
70.0%
|
68.8% |
Turnover per employee |
249
|
272
|
242 |
Profit as a percentage of turnover |
16.3%
|
22.2%
|
21.8% |
Return on assets (ROA) |
7.0%
|
15.5%
|
14.1% |
Current ratio |
206.4%
|
249.0%
|
249.7% |
Return on equity (ROE) |
8.3%
|
21.3%
|
19.6% |
Change turnover |
26,676
|
30,014
|
13,662 |
Change turnover % |
19%
|
27%
|
13% |
Chg. No. of employees |
157
|
20
|
34 |
Chg. No. of employees % |
30%
|
4%
|
7% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.